「商汤医疗」再获数亿元战略融资，A轮投后估值超30亿元｜36氪独家

Core Viewpoint - SenseTime Medical has completed a strategic financing round of several hundred million yuan, indicating strong investor interest and confidence in the company's AI-driven healthcare solutions [1][4]. Financing and Valuation - The company has initiated its Series A financing, with a post-investment valuation exceeding 3 billion yuan and subscription amounts surpassing 500 million yuan [2][4]. - Previous investments in early 2023 included over 100 million yuan from major industry players [1]. Technology and Product Development - SenseTime Medical leverages AI technology to promote the construction of "future smart hospitals," utilizing a "fusion of general and specialized" technical approach [2]. - The core technology includes the "Da Yi" medical language model, which is trained on vast amounts of high-quality medical knowledge, enabling capabilities in self-diagnosis, medication consultation, structured imaging reports, and clinical decision support [2]. - The multi-modal medical image foundational model group addresses various data modalities, supporting efficient model training to overcome challenges in medical data scarcity and annotation difficulties [2]. Strategic Positioning - The CEO emphasizes that while pure technology can provide a competitive edge, a rich product matrix and a capital-supported industrial ecosystem are harder to replicate, which is crucial for long-term success [2]. - Since 2018, the company has adopted a platform-based approach to empower comprehensive hospital diagnosis and treatment, covering clinical diagnosis, intelligent decision-making, patient services, and medical research [2]. Market Demand and Competitive Strategy - The platform strategy aligns with hospitals' implicit needs for extensible products rather than multiple software solutions from various vendors [3]. - To avoid price wars in standardized software, SenseTime Medical has established a dual middle platform system for intelligent agent development and model application production, creating a differentiated advantage [3]. Commercialization and Future Plans - Following the "1+X" strategy, SenseTime Medical operates independently in the market, focusing on large-scale "full-hospital intelligence" projects while also expanding standardized software modules to grassroots hospitals [5]. - The company aims to attract resourceful shareholders to foster a collaborative ecosystem, emphasizing that financing is not solely for capital but also for partnership development [5].